Skip to main content
Premium Trial:

Request an Annual Quote

HHS Advisory Committee to Issue Report on Genetic Testing Next Month

SAN FRANCISCO (GenomeWeb News) – A US Department of Health and Human Services committee next month will issue its final report with suggestions for the Food and Drug Administration’s role in overseeing pharmacogenomic tests, a high-ranking FDA official said today.

Speaking today at the Molecular Medicine Tri-Conference here, Steve Gutman, director of the FDA's Office of In Vitro Diagnostic Device Evaluation and Safety, said that the HHS Secretary’s Advisory Committee on Genetics, Health, and Society would issue a report containing more than 200 pages of recommendations. He said the guidelines, which are being published ahead of schedule, “will be challenging for HHS to address.”

Guttman added that it is too early to say how much more of a role FDA will play than it currently does in the regulatory process for genetic tests.

Last year, the SACGHS issued a draft report in which it said that there is not enough data regarding how pharmacogenomic tools can inform clinical decisions, such as dose adjustments, and the FDA needs help defining these gaps in knowledge.

The draft report recommended the FDA work with professional medical organizations to develop dosing guidelines, encourage clinical trials exploring the relationships between diagnostics and drug response, and seek input from stakeholders in industry and academia to translate the findings from prospective studies into treatment guidelines.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.